All In Biotech

Drug Trial Radar · NCT04610541

REMdesivir-HU Clinical Study and Severe Covid-19 Patients

Open-label Study to Assess the Safety of REMdesivir-HU as Eligible Novel therapY for Moderate and Severe Covid-19 Patients

Last checked: Nov 20, 2026Latest source record: Nov 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

2,000

Planned (sponsor's estimate)

Start

Oct 12, 2020

Primary completion

Oct 30, 2021

Study completion Nov 30, 2021

Sponsor

Lead sponsor
University of PecsAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
HECRIN Consortium; Ministry of Innovation and Technology, Hungary
First posted
Oct 30, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 12 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3, open-label, multi-center, interventional safety study of REM therapy in participants 12 years of age or older with COVID-19, pneumonia and oxygen supplementation.

Conditions

  • SARS-CoV-2 Infection

Interventions

  • Remdesivir-HUDrug

    Remdesivir-HU 100 mg concentrate for solution for infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the safety and tolerability of REM use in Hungary in the conditionally approved indication (EMA)Time frame: 30 days

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Department of Pulmonology Semmelweis University

    Budapest, Hungary

  • National Korányi Institute for Pulmonology

    Budapest, Hungary

  • North - Central Buda Center New St. János Hospital

    Budapest, Hungary

  • Institute of Infectology, University of Debrecen

    Debrecen, Hungary

  • 1st Department of Medicine, University of Pécs

    Pécs, Hungary

  • Department of Internal Medicine University of Szeged

    Szeged, Hungary

  • First Department of Internal Medicine, University of Szeged

    Szeged, Hungary

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.